{{Rsnum
|rsid=1644305
|Chromosome=5
|position=133867905
|Orientation=minus
|GMAF=0.3053
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 35.4 | 49.2 | 15.4
| HCB | 68.9 | 31.1 | 0.0
| JPT | 68.2 | 31.8 | 0.0
| YRI | 49.2 | 41.3 | 9.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 68.9 | 31.1 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=18951430
|Trait=Attention-deficit/hyperactivity disorder and conduct disorder
|Title=Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study
|RiskAllele=A
|Pval=0.000008
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs1644305
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18951430; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study. (Initial Sample Size: 938 affected trios; Replication Sample Size: NR); (Region: 5q31.1; Reported Gene(s): C5orf15; Risk Allele: rs1644305-A); (p-value= 0.000008).This variant is associated with Attention-deficit/hyperactivity disorder and conduct disorder.
|Drugs=
|Drug Classes=
|Diseases=Attention Deficit Disorder with Hyperactivity
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740777
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1644305
|overall_frequency_n=47
|overall_frequency_d=128
|overall_frequency=0.367188
|n_genomes=30
|n_genomes_annotated=0
|n_haplomes=39
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}